Paul Kocheril, MD
Radiation Oncology · Flint, MINPI 1548298375
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,859 of the $3,063 with a category attached, or 60.7%. Icotec Medical Inc. accounts for 74.6% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $2,547, more than ten times the $85 reported in 2019.
Across 30 payments — averaging $102.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icotec Medical Inc.$2K
- Teleflex LLC$146
- Telix Pharmaceuticals$129
- Boston Scientific$90
- AstraZeneca$85
- Brainlab, Inc.$52
- plus $275 from 9 others
What the payments were for
- Travel & lodging$1,85961%
- Food & beverage$1,20439%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icotec Medical Inc. | 9 | $2,285 |
| Teleflex LLC | 3 | $146 |
| Telix Pharmaceuticals | 1 | $129 |
| Boston Scientific | 2 | $90 |
| AstraZeneca | 2 | $85 |
| Brainlab, Inc. | 2 | $52 |
| Novocure Inc. | 2 | $46 |
| Reflexion Medical, Inc. | 1 | $44 |
| Siemens Medical Solutions USA, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| AbbVie | 1 | $30 |
| Genentech USA, Inc. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Varian Medical Systems, Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$258
How this compares
$3,063 in reported general payments places this provider in the 80th percentile of 198 radiation oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 29 | $1,770 |
| Tamsulosin Hcl | 87 | $1,598 |
| Gabapentin | 37 | $688 |
| Oxybutynin Chloride | 24 | $265 |
| SsdSilver Sulfadiazine | 20 | $199 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Flint
- Hesham GayarFlint$2K
- Christian HydeFlint$985
- Frank ViciniPontiac$231K
- Thomas BoikeClarkston$171K
- Farzan SiddiquiDetroit$72K
- Daniel WahlAnn Arbor$42K
- Daniel ChangAnn Arbor$38K
- Shruti JollyAnn Arbor$30K
- Brandon ManciniGrand Rapids$30K
- Alvaro MartinezFarmington Hills$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.